- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1375
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1375 companies
Genomma Lab Internacional. de
Market Cap: Mex$17.6b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$18.01
7D
-11.9%
1Y
-19.6%
Shanxi Zhendong PharmaceuticalLtd
Market Cap: CN¥6.8b
Engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally.
300158
CN¥6.57
7D
-10.7%
1Y
69.3%
ARS Pharmaceuticals
Market Cap: US$951.7m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$9.54
7D
-3.9%
1Y
-34.3%
Saudi Pharmaceutical Industries and Medical Appliances
Market Cap: ر.س3.5b
Develops, manufactures, and markets of medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middles East, Egypt, and Morocco.
2070
ر.س29.10
7D
4.3%
1Y
-14.8%
Oxford Biomedica
Market Cap: UK£688.6m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£5.73
7D
-0.5%
1Y
51.0%
Guizhou Xinbang Pharmaceutical
Market Cap: CN¥6.5b
Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally.
002390
CN¥3.42
7D
-3.1%
1Y
0.6%
GNI Group
Market Cap: JP¥135.4b
Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.
2160
JP¥2,367.00
7D
-8.1%
1Y
-20.5%
Upstream Bio
Market Cap: US$903.0m
A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.
UPB
US$16.31
7D
-5.6%
1Y
n/a
Immatics
Market Cap: US$891.0m
A clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States.
IMTX
US$7.05
7D
6.7%
1Y
-39.9%
Shanghai Kaibao PharmaceuticalLtd
Market Cap: CN¥6.3b
Engages in the research, development, production, and sale of modern Chinese medicines primarily in China.
300039
CN¥6.03
7D
-1.8%
1Y
6.0%
Novogene
Market Cap: CN¥6.3b
Provides genomic services and solutions in Mainland China, Hong Kong, Macau, Taiwan, and internationally.
688315
CN¥15.32
7D
-1.2%
1Y
34.5%
MedCap
Market Cap: SEK 8.3b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 553.00
7D
-9.3%
1Y
9.7%
CorMedix
Market Cap: US$877.4m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$11.12
7D
-4.9%
1Y
35.1%
Jianmin Pharmaceutical GroupLtd
Market Cap: CN¥6.2b
Manufactures and sells medicines in China.
600976
CN¥40.20
7D
-2.9%
1Y
-14.3%
Strides Pharma Science
Market Cap: ₹77.4b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹815.50
7D
-6.4%
1Y
-42.1%
Marksans Pharma
Market Cap: ₹76.8b
Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.
MARKSANS
₹164.38
7D
-8.2%
1Y
-46.2%
Valneva
Market Cap: €741.9m
A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
VLA
€4.32
7D
1.2%
1Y
57.1%
Aarti Pharmalabs
Market Cap: ₹76.4b
Manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.
AARTIPHARM
₹824.05
7D
-11.4%
1Y
33.8%
Taysha Gene Therapies
Market Cap: US$859.3m
A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.
TSHA
US$3.06
7D
2.3%
1Y
45.7%
MedinCell
Market Cap: €736.7m
A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.
MEDCL
€22.26
7D
5.5%
1Y
39.1%
FDC
Market Cap: ₹75.7b
Manufactures and trades in pharmaceutical products in India, the United States, and internationally.
531599
₹454.25
7D
-6.6%
1Y
-15.9%
Jiangsu Yahong Meditech
Market Cap: CN¥6.1b
A pharmaceutical company, focuses on urogenital tumors and women's health in China and internationally.
688176
CN¥10.52
7D
-3.9%
1Y
81.1%
Geron
Market Cap: US$848.6m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.27
7D
-3.8%
1Y
-71.3%
Mega Lifesciences
Market Cap: ฿27.2b
Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.
MEGA
฿30.75
7D
-2.4%
1Y
-21.2%
Shenzhen Weiguang Biological Products
Market Cap: CN¥6.0b
Shenzhen Weiguang Biological Products Co., Ltd.
002880
CN¥26.55
7D
-1.8%
1Y
0.04%
ChemPartner PharmaTechLtd
Market Cap: CN¥6.0b
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide.
300149
CN¥11.41
7D
-10.1%
1Y
87.7%
Jinghua Pharmaceutical Group
Market Cap: CN¥6.0b
Engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China.
002349
CN¥7.15
7D
-2.3%
1Y
-3.1%
Seegene
Market Cap: ₩1.2t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩25,000.00
7D
-6.0%
1Y
-2.9%
Sopharma AD
Market Cap: лв1.4b
Produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.
SFA
лв2.70
7D
2.3%
1Y
35.5%
Tianjin Lisheng PharmaceuticalLtd
Market Cap: CN¥5.8b
Engages in the research and development, production, and sale of pharmaceutical products in China.
002393
CN¥22.69
7D
-2.5%
1Y
38.4%
Zhejiang Int'l GroupLtd
Market Cap: CN¥5.8b
Engages in the wholesale and retail of pharmaceuticals and medical devices.
000411
CN¥11.09
7D
0.2%
1Y
11.5%
CareDx
Market Cap: US$801.6m
Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.
CDNA
US$14.87
7D
0.7%
1Y
-50.1%
ProKidney
Market Cap: US$800.4m
A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.
PROK
US$2.62
7D
-3.3%
1Y
28.4%
Rezolute
Market Cap: US$800.0m
A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.
RZLT
US$8.77
7D
7.0%
1Y
79.7%
Akums Drugs and Pharmaceuticals
Market Cap: ₹70.2b
Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.
AKUMS
₹446.65
7D
-6.3%
1Y
-46.4%
Hubei Hongyuan Pharmaceutical Technology
Market Cap: CN¥5.6b
Engages in the production and sale of pharmaceutical products in China and internationally.
301246
CN¥14.20
7D
-1.7%
1Y
10.8%